BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31215858)

  • 41. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors.
    Shiro H; Sato Y; Toyonaga Y; Hanaki H; Sunakawa K
    J Infect Chemother; 2015 Apr; 21(4):247-56. PubMed ID: 25596977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N; Davies TA; Goldschmidt R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.
    Li X; Mariano N; Rahal JJ; Urban CM; Drlica K
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4460-2. PubMed ID: 15504883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.
    Kawai Y; Nakura Y; Wakimoto T; Nomiyama M; Tokuda T; Takayanagi T; Shiraishi J; Wasada K; Kitajima H; Fujita T; Nakayama M; Mitsuda N; Nakanishi I; Takeuchi M; Yanagihara I
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2358-64. PubMed ID: 25645833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.
    Li X; Mariano N; Rahal JJ; Urban CM; Drlica K
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3570-2. PubMed ID: 15328129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong.
    Ho PL; Chow KH; Mak GC; Tsang KW; Lau YL; Ho AY; Lai EL; Chiu SS
    Emerg Infect Dis; 2004 Nov; 10(11):1960-2. PubMed ID: 15550208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotics susceptibility of quinolones against Salmonella spp. strains isolated and molecularly sequenced for gyrA gene.
    Macías-Farrera GP; de Oca Jiménez RM; Varela-Guerrero J; Tenorio-Borroto E; Rivera-Ramírez F; Monroy-Salazar HG; Yong-Angel G
    Microb Pathog; 2018 Jan; 114():286-290. PubMed ID: 29208542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and characterisation of quinolone resistance genes in Aeromonas spp. isolated from pet turtles in South Korea.
    Wimalasena SHMP; De Silva BCJ; Hossain S; Pathirana HNKS; Heo GJ
    J Glob Antimicrob Resist; 2017 Dec; 11():34-38. PubMed ID: 28743647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
    Capilla S; Ruiz J; Goñi P; Castillo J; Rubio MC; Jiménez de Anta MT; Gómez-Lus R; Vila J
    J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.
    Lunn AD; Fàbrega A; Sánchez-Céspedes J; Vila J
    Int Microbiol; 2010 Mar; 13(1):15-20. PubMed ID: 20890836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of type III secretion system virulence and mutations in gyrA and parC genes among quinolone-resistant strains of Pseudomonas aeruginosa isolated from imported shrimp.
    Tran QT; Nawaz MS; Deck J; Foley S; Nguyen K; Cerniglia CE
    Foodborne Pathog Dis; 2011 Mar; 8(3):451-3. PubMed ID: 21117986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
    Tamang MD; Nam HM; Kim A; Lee HS; Kim TS; Kim MJ; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2011 Nov; 8(11):1199-206. PubMed ID: 21877929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of virulence genes and role of gyrA mutations in quinolone resistant and susceptible strains of Salmonella Weltevreden and Newport isolated from seafood.
    Deekshit VK; Kumar BK; Rai P; Karunasagar I; Karunasagar I
    J Appl Microbiol; 2015 Oct; 119(4):970-80. PubMed ID: 26249136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apigenin as an anti-quinolone-resistance antibiotic.
    Morimoto Y; Baba T; Sasaki T; Hiramatsu K
    Int J Antimicrob Agents; 2015 Dec; 46(6):666-73. PubMed ID: 26526895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Mechanisms of beta-lactam and quinolone resistance in Haemophilus influenzae].
    Ubukata K
    Nihon Rinsho; 2012 Feb; 70(2):247-50. PubMed ID: 22413526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones.
    Gibello A; Porrero MC; Blanco MM; Vela AI; Liébana P; Moreno MA; Fernández-Garayzábal JF; Domínguez L
    Appl Environ Microbiol; 2004 Jan; 70(1):599-602. PubMed ID: 14711693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
    Kulkarni S; Bala M; Sane S; Pandey S; Bhattacharya J; Risbud A
    Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.